期刊文献+

腺性膀胱炎中肿瘤相关指标的改变和临床分型的探讨 被引量:34

Expression of cancer-related indices in different types of cystitis glangularis and clinical significance thereof
原文传递
导出
摘要 目的探讨腺性膀胱炎的良恶性及癌变可能性,并探讨临床分型的合理性。方法根据膀胱镜下表现将腺性膀胱炎分为低危型及高危型。25例腺性膀胱炎新鲜组织,其中低危型12例,高危型13例,用流式细胞术检测其DNA含量;38例腺性膀胱炎蜡块组织,其中低危型20例,高危型18例,用免疫组织化学的方法研究增殖细胞核抗原(PCNA)、突变型p53、p21ras、bcl2及Rb等的表达。结果正常二倍体DNA指数为1.00±0.03,低危型腺性膀胱炎组为1.01±0.05,高危型组为1.05±0.07,低危型组和高危型组之间的差异无统计学意义(t=1.639,P=0.115);PCNA及p53在低危型组均表达阴性,在高危型组分别表达5例(27.8%)及4例(22.2%),两组之间的差异有统计学意义(P值分别为0.017、0.041);p21ras、bcl2及Rb在低危型组和高危型组的表达差异无统计学意义。结论高危型腺性膀胱炎和低危型腺性膀胱炎同为良性病变。高危型有发生恶变的可能性,因此将腺性膀胱炎分为高危型及低危型具有合理性。p53基因可能在高危型腺性膀胱炎的恶变过程中有重要作用。 Objective To explore the rationality of clinical typing of cystitis glandularis (CG) and the potential of cancerization of different types of CG.Methods Flow cytometry was performed to examine the ploidy of 25 fresh bladder specimens of patients with CG resected during operation, 13 high risk type and 12 low risk type, and 7 specimens of normal mucosa of bladder, by calculating the DNA index (DI). Immunohistochemistry was used to detect the expression of proliferating cell nuclear antigen (PCNA), mutant p53, p21ras, Rb, and bcl-2 in other 38 preserved specimens of CG resected during operation, 18 high risk type and 20 low risk type, and 5 specimens of normal bladder. Results The DI was 1.00±0.03 in the normal bladder group, 1.05±0.07 in the high risk type CG group, and 1,01±0.05 in the low risk type CG, without significant differences between any 2 groups (t=-1.639, P=0.115). The expression of PCNA and expression of p53 were negative in the low risk group, and PCNA was expressed in 5 specimens of high risk type CG (27.8%), and not expressed in the low risk type CG (P=0.017). p53 was expressed in 4 specimens of high risk type CG (22.2%), and not expressed in the low risk type CG (P=0.041). There were no significant differences in the expression of p21, Rb, and bcl-2 between the high and low risk groups.Conclusion High risk type and low risk type of CG are both benign lesions. High risk type CG may be more likely to cancerize. It is reasonable to distinguish different types of CG. p53 gene may play an important role in the canceration of CG.
出处 《中华医学杂志》 CAS CSCD 北大核心 2005年第26期1842-1844,共3页 National Medical Journal of China
  • 相关文献

参考文献10

  • 1Chen ZQ, Lan RZ, Ye ZQ, et al. Analysis on pathogenesis of 50 cases of bladder proliferative lesions. J Huazhong Univ Sci Technolog Med Sci, 2003, 23:294-296.
  • 2Lage AL, Gillett NA, Gerlach RF, et al. The prevalence and distribution of proliferative and metaplastic changes in normal appearing canine bladders. J Urol, 1989, 141:993-997.
  • 3Shaw JL, Gislason GJ, Imbriglia JE. Transition of cystitis glandularis to primary adenocarcinoma of the bladder. J Urol, 1958, 79:815-822.
  • 4Bryan RT, Nicholls JH, Harrison RF, et al. The role of beta-catenin signaling in the malignant potential of cystitis glandularis. J Urol, 2003, 170:1892-1896.
  • 5Barlogie B, Raber MN, Schumann J, et al. Flow cytometry in clinical cancer research. Cancer Res, 1983, 43:3982-3997.
  • 6许岸高,李韶光,刘集鸿,浓剑刚,姜泊,甘爱华.胃癌癌前病变演化与细胞凋亡和增殖的关系[J].中华医学杂志,1999,79(3):185-186. 被引量:69
  • 7Esrig D, Spruck CH 3rd, Nichols PW, et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol, 1993, 143:1389-1397.
  • 8Cordon-Cardo C, Wartinger D, Petrylak D, et al. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst, 1992, 84:1251-1256.
  • 9Levesque P, Ramchurren N, Saini K, et al. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations. Int J Cancer, 1993, 55:785-790.
  • 10Lu QL, Laniado M, Abel PD, et al. Expression of bcl-2 in bladder neoplasms is a cell lineage associated and p53-independent event. Mol Pathol, 1997, 50:28-33.

二级参考文献1

  • 1Iwanga T,Gastroenterology,1993年,105卷,1089页

共引文献68

同被引文献274

引证文献34

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部